The biopharmaceutical market in South East Asia was valued at US$ 18.4 Billion in 2023. Projections indicate that the market will reach US$ 37.6 Billion by 2032, growing at a compound annual growth rate (CAGR) of 8.25% from 2024 to 2032. https://www.imarcgroup.com/south-east-asia-biopharmaceutical-market